Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 13;9(1):11730.
doi: 10.1038/s41598-019-48029-z.

Oncogenic G12D mutation alters local conformations and dynamics of K-Ras

Affiliations

Oncogenic G12D mutation alters local conformations and dynamics of K-Ras

Sezen Vatansever et al. Sci Rep. .

Abstract

K-Ras is the most frequently mutated oncoprotein in human cancers, and G12D is its most prevalent mutation. To understand how G12D mutation impacts K-Ras function, we need to understand how it alters the regulation of its dynamics. Here, we present local changes in K-Ras structure, conformation and dynamics upon G12D mutation, from long-timescale Molecular Dynamics simulations of active (GTP-bound) and inactive (GDP-bound) forms of wild-type and mutant K-Ras, with an integrated investigation of atomistic-level changes, local conformational shifts and correlated residue motions. Our results reveal that the local changes in K-Ras are specific to bound nucleotide (GTP or GDP), and we provide a structural basis for this. Specifically, we show that G12D mutation causes a shift in the population of local conformational states of K-Ras, especially in Switch-II (SII) and α3-helix regions, in favor of a conformation that is associated with a catalytically impaired state through structural changes; it also causes SII motions to anti-correlate with other regions. This detailed picture of G12D mutation effects on the local dynamic characteristics of both active and inactive protein helps enhance our understanding of local K-Ras dynamics, and can inform studies on the development of direct inhibitors towards the treatment of K-RasG12D-driven cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
K-Ras switch mechanism and 3D structure. (A) Cartoon representation of K-Ras switch mechanism between GTP-bound (active) to GDP-bound (inactive) forms and the GTP hydrolysis reaction. (B) Cartoon representation of K-Ras protein consisting of secondary structures. Blue: β-sheets, green: α-helices, pink: P-loop, light pink: SI region, purple: SII region. (C) Zoomed-in visualization of the P-loop. Grey: Wild-type, pink: G12D mutant. Residues G12 and D12 are in stick representation. (D) G12D mutation site (red), protein-protein interaction site residues for its regulator and downstream effector proteins (green) and schematic representation of K-Ras sequence (residues 1–169).
Figure 2
Figure 2
Conformational changes in K-Ras upon G12D mutation. (A) The differences in average pairwise distances (ΔR¯ij) where K-RasWT is the reference state. Red dots (positive ΔR¯ij values) show that pairs move further apart and blue dots (negative ΔR¯ij values) show that pairs move closer in K-RasG12D. (B) The average of all ΔR¯ij values for each residue, ΔR¯i. The initial state is K-RasWT and the final state is K-RasG12D. The residues which move away from their neighbors have positive values and dominate the mutant protein; residues that move close to their neighbors have negative values.
Figure 3
Figure 3
Distribution of distances between residue pairs in SII-α3 region. Distance distributions of Cα of residue pairs in K-RasWT-GTP (black) and K-RasG12D-GTP (red) (A) Q61-D92, (B) E62-H95, (C) Y64-H95; in K-RasWT-GDP (grey) and K-RasG12D-GDP (pink) (D) Q61-D92, (E) E62-H95, (F) Y64-H95.
Figure 4
Figure 4
Distribution of distances between residue pairs in the P loop-SII region. Distance distributions between Cαs of residue pairs in K-RasWT-GTP (black) and K-RasG12D-GTP (red) (A) A11-Q61, (B) G12D-Q61, (C) G12D-Q61; in K-RasWT-GDP (grey) and K-RasG12D-GDP (pink) (D) A11-Q61, (E) G12D-Q61, (F) G12D-Q61.
Figure 5
Figure 5
Distance distributions of residue pairs which get closer after G12D mutation in K-Ras-GTP in K-RasWT (black) and K-RasG12D (red). Distance distribution of Cαs of residue pairs in K-RasWT-GTP (black) and K-RasG12D-GTP (red) (A) L23-V152, (B) L23-F156; in K-RasWT-GDP (grey) and K-RasG12D-GDP (pink) (C) L23-V152, (D) L23-F156.
Figure 6
Figure 6
Dynamic changes in K-Ras upon G12D mutation. (A) RMSF values of K-RasWT-GTP (black) and K-RasG12D-GTP (red) residues. (B) RMSF values of K-RasWT-GDP (grey) and K-RasG12D-GDP (pink) residues.
Figure 7
Figure 7
The maps of correlation coefficients from the motions of correlated residues in (A) K-RasWT-GTP, (B) K-RasG12D-GTP, (C) K-RasWT-GDP and (D) K-RasG12D-GDP. Red dots show positive correlations and blue dots show negative correlations.

References

    1. Stephen AG, Esposito D, Bagni RK, McCormick F. Dragging ras back in the ring. Cancer Cell. 2014;25:272–281. doi: 10.1016/j.ccr.2014.02.017. - DOI - PubMed
    1. Forbes SA, et al. COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43:D805–811. doi: 10.1093/nar/gku1075. - DOI - PMC - PubMed
    1. Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res. 2012;72:2457–2467. doi: 10.1158/0008-5472.CAN-11-2612. - DOI - PMC - PubMed
    1. Pao W, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. Plos Med. 2005;2:57–61. doi: 10.1371/journal.pmed.0020017. - DOI - PMC - PubMed
    1. Amado RG, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:1626–1634. doi: 10.1200/JCO.2007.14.7116. - DOI - PubMed

Publication types

Substances